Search companies or stocks...
XGNExagen Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States.…
Current stock price of Exagen Inc. (XGN) stock is $7.510. The stock price is +5.48% higher in the session. The intraday range can be seen from this page. Volume of Exagen Inc. (XGN) stock is 244.29K.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Exagen Inc. (XGN) can change with earnings, company news, and overall market sentiment. Exagen Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Exagen Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for XGN on this page is -9.27. EPS on this page is -0.81. Compare those figures with peers and growth expectations before deciding if the current Exagen Inc. price is justified.
Historical performance for Exagen Inc. (XGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how XGN reacted to past earnings and market events.
Buying Exagen Inc. (XGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
